GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: VX-121 | VX121
vanzacaftor is an approved drug
Compound class:
Synthetic organic
Comment: Vanzacaftor (VX-121) is a cystic fibrosis transmembrane regulator (CFTR) protein corrector for class II CFTR mutations (the most common being F508del). Its biological activity is similar to that of elexacaftor. Like elexacftor, off-target effects on K+ channels have been reported [2].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. UK MHRA (2025) | US FDA (2024) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 11971 | vanzacaftor |
Synonyms ![]() |
| VX-121 | VX121 |
Database Links ![]() |
|
| CAS Registry No. | 2374124-49-7 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL5314934 |
| DrugBank Ligand | DB18373 |
| GtoPdb PubChem SID | 507750328 |
| PubChem CID | 139399801 |
| Search Google for chemical match using the InChIKey | VCSUIBJKYCVWNF-NRFANRHFSA-N |
| Search Google for chemicals with the same backbone | VCSUIBJKYCVWNF |
| Search PubMed clinical trials | vanzacaftor |
| Search PubMed titles | vanzacaftor |
| Search PubMed titles/abstracts | vanzacaftor |
| UniChem Compound Search for chemical match using the InChIKey | VCSUIBJKYCVWNF-NRFANRHFSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | VCSUIBJKYCVWNF-NRFANRHFSA-N |